Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

about

Use of antibodies and immunoconjugates for the therapy of more accessible cancers.Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.

P2860

Q37174938-30DBA926-0FA6-4149-A271-1BDD6909AF3F Q37299843-3701206A-D15B-4147-9445-1EF94E542DCF

P2860

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q36689156

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@ast

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@en

type

Item

label

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@ast

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@en

prefLabel

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@ast

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@en

P1476

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

@en

P2093

Adriano Venditti

http://www.w3.org/2001/XMLSchema#string

Francesco Buccisano

http://www.w3.org/2001/XMLSchema#string

Giovanni Del Poeta

http://www.w3.org/2001/XMLSchema#string

Luca Maurillo

http://www.w3.org/2001/XMLSchema#string

Maria Ilaria Del Principe

http://www.w3.org/2001/XMLSchema#string

Pasquale Niscola

http://www.w3.org/2001/XMLSchema#string

Sergio Amadori

http://www.w3.org/2001/XMLSchema#string

P2860

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

Genomic aberrations and survival in chronic lymphocytic leukemia

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

Campath-1H monoclonal antibody therapy.

P304

1787-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.6.12.1787

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6619754

http://www.w3.org/2001/XMLSchema#string

P698

17181492

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

about

P2860

P2860

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921